Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • MooseBoys@lemmy.world
    link
    fedilink
    English
    arrow-up
    14
    ·
    1 year ago

    when selling their property

    Except a significant portion of these drugs were developed with government (taxpayer-funded) subsidies and research grants.